• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • PPI
  • BSE Code : 2393.0
  • ISIN : INE107F01022
234.42 1 (0.27%)
  • As on 28 Mar 2025 (EOD)
  • Today’s Low

    230.74
  • Today’s High

    248.00
  • Open

    233.80
  • Perv Close

    233.80
  • 52W Low

    131.20
  • 52W High

    323.53

Key Indicators

  • P/E(TTM)

    41.90

  • Mar.Cap (₹Cr.)

    768.21

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.83

  • Debt-Equity Ratio

    0.27

  • AGM Date

    28-Mar-2025

  • EPS

    5.60

  • P/E Ratio

    41.90

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    768.21

  • RONW (%)

    49.77

  • ROCE (%)

    33.46

Score Board

  • Equity (₹ in Cr.)

    32.77

  • BV (₹)

    11.80

  • Sales( ₹ in Cr.)

    575.65

  • NP (in Cr.)

    29.91

  • NP Var(%)

    397.0

  • Div%

    0.0

  • CPS (₹)

    13.10

  • EPS (₹)

    9.10

  • Traded Value (₹ in Lakhs)

    768.96

  • 52 Week High

    323.53

  • 52 Week Low

    131.20

  • Price BSE

    235.0

  • Price NSE

    234.00

  • Market Capital( in Cr.)

    768.96

  • P/C Ratio

    17.90

  • P/E Ratio

    25.70

  • Price Vs.BV

    9.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 575.65 499.65 511.19 392.52 367.45 391.37
Excise Duty 574.48 498.18 507.24 387.10 362.59 386.91
Net Sales 575.65 499.65 511.19 392.52 367.45 391.37
Other Income 2.99 0.91 1.51 2.40 1.14 9.33
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 578.64 500.56 512.69 394.92 368.59 400.70
EXPENDITURE :
Raw Materials 574.48 498.18 507.24 387.10 362.59 386.91
Power & Fuel Cost 574.48 498.18 507.24 387.10 362.59 386.91
Employee Cost 86.92 81.00 74.81 64.15 67.48 75.89
Other Manufacturing Expenses 19.69 14.86 14.36 16.42 16.29 17.59
Selling & Administrative Expenses 60.37 46.02 56.06 45.76 55.74 64.67
Miscellaneous Expenses 19.69 14.86 14.36 16.42 16.29 17.59
Less : Pre-operative Expenses Capitalised :
Total Expenditure 547.86 510.25 507.93 407.33 386.56 425.69
Operating Profit 36.04 31.15 30.35 26.84 28.77 21.47
Interest 29.18 21.39 20.61 23.07 32.87 39.88
Gross Profit 30.78 -10.29 81.13 -12.41 64.67 -24.99
Depreciation 13.03 12.38 11.45 9.75 9.68 9.97
Profit Before Tax 30.78 -10.29 81.13 -12.41 64.67 -24.99
Tax 0.00 0.00 0.00 2.27 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.38 0.11 -0.35 -2.07 0.21 -0.14
Reported Net Profit 30.40 -10.40 81.47 -12.61 64.46 -24.85
Extraordinary Items 30.78 -10.29 81.13 -12.41 64.67 -24.99
Adjusted Net Profit 30.40 -10.40 81.47 -12.61 64.46 -24.85
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 30.40 -10.40 81.47 -12.61 64.46 -24.85
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.29 -3.18 25.29 -5.04 -7.59 -10.48
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    39.76%

  • Public Share Holding

    60.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 3,024,000 9.23 3,024,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,024,000 9.23 3,024,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,005,561 30.53 10,005,561 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,005,561 30.53 10,005,561 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 521 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 275,372 0.84 275,372 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 66 0.00 66 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 275,959 0.84 275,438 8
2] Non Institution
Bodies Corporate 3,429,780 10.47 3,428,427 179
Clearing Members 170,928 0.52 170,928 42
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 411,180 1.25 409,061 216
Foreign Non Institution Other 94,680 0.29 0 1
Hindu Undivided Families 1,377,579 4.20 1,377,513 524
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,564,539 16.98 5,564,539 89
Individuals holding nominal share capital up to Rs. 1 lakh 7,415,047 22.63 7,288,198 16,908
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 452,715 1.38 452,715 4
Sub Total 19,464,978 59.40 19,239,911 17,989
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 32,770,498 100.00 29,520,910 17,999

Company Background

Wanbury LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wanbury Ltd
  • BSE Code : 2393.0
  • ISIN : INE107F01022
  • Incorporation Year

    1988

  • Registered Office

    BSEL Tech Park B-Wing 10th Flr
    Sector 30 A Opp Vashi Rly Stat, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-67942222

  • FAX

    91-22-67942111/333

  • Chairman

    K Chandran

  • Managing Director

  • Company Secretary

    Jitendra J Gandhi

  • Auditor

    V Parekh & Associates/Kapoor & Parekh Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    Unit No 1 Luthra Ind,
    Andheri Kurla Road ,Safed Pool Andheri(E
    Mumbai - Mumbai - 400 072

Wanbury Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wanbury 234.65 578.64 575.65 41.90 32.14
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92